SEARCH RESULTS FOR:
Timothy Beale
PRESIDENT & CEO, REVELO RESOURCES
Chile Mining 2019 Pre-Release Edition
Chile-based Revelo Resources wants to take its prospect generation business model to the next level.
Stefano Marani
MANAGING DIRECTOR AND CEO, RENERGEN
Africa Oil and Gas 2019
Renergen discusses the next steps for its Virginia gas field – South Africa’s only onshore petroleum production project.
Samir Gandhi & Kartik Gandhi
MANAGING DIRECTOR AND CEO & DIRECTOR, GANDHI AUTOMATIONS
India Pharmaceuticals 2019
Gandhi Automations is taking a leading role in introducing the benefits of automation to Indian manufacturers – including the pharma industry.
Paul Alexander
MANAGING DIRECTOR, STORM PROCUREMENT
MACIG 2020 Western & Southern Africa Pre-Release Edition
Storm Procurement purchases goods from 27 different countries across four continents to support miners’ access to high quality supplies.
Chris Stafford
PRESIDENT, C.J. STAFFORD & ASSOCIATES
C.J. Stafford & Associates is a boutique style executive search company that was established in 1981 and is recognized as specialists in recruiting for the Mining, Engineering and Construction industries.
Professor Fazilet Vardar Sukan
DIRECTOR, SUNUM (SABANCI UNIVERSITY)
The Sabanci University Nanotechnology Research and Application Center (SUNUM) brings together researchers with expertise spanning advanced materials, nano-biotechnology, nano-electronics, micro-nano fluidics, micro-nano-electromechanical systems and nano-engineering.
Mohal K Sarabhai
CEO, ASENCE PHARMA PRIVATE LIMITED, (AMBALAL SARABHAI ENTERPRISES LTD (ASE) GROUP)
India Pharmaceuticals 2019
ASE is one of the oldest pharmaceutical companies in India and re-emerged as a parent company for different subsidiaries.
Mike Adendorff
CHIEF EXECUTIVE OFFICER, AARD MINING EQUIPMENT
AARD designs, manufactures, services and supports a range of mining equipment in sub-Saharan Africa.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
